Cited by 1,772Liver Disease Diagnosis and TreatmentLiver physiology and pathologyDrug-Induced Hepatotoxicity and Protection

The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.

Molecular mediators of hepatic steatosis and liver injury

Open access

Browning, Jeffrey D., Horton, Jay D.·2004·Journal of Clinical Investigation

DOI 10.1172/jci200422422PMC PMC449757

Open this paper in CoChat — free account Open PDF

Abstract

Nonstandard abbreviations used: acetyl-CoA carboxylase (ACC); AMP-activated protein kinase (AMPK); basic helix-loop-helix-leucine zipper (bHLH-Zip); carbohydrate response element binding protein (ChREBP); carnitine palmitoyl transferase-1 (CPT-1); diethylaminoethoxyhexestrol (DEAEH); liver function test (LFT); liver-type pyruvate kinase (L-PK); malondialdehyde (MDA); mitochondrial respiratory chain (MRC); nonalcoholic fatty-liver disease (NAFLD); nonalcoholic steatohepatitis (NASH); polyunsaturated fatty acid (PUFA); reactive oxygen species (ROS); stearoyl-CoA desaturase (SCD); trans-4-hydroxy-2-nonenal (HNE). Conflict of interest:The authors have declared that no conflict of interest exists.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci200422422

Cites

87 of 87 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Weight-Reducing Effects of the Plasma Protein Encoded by the obese Gene
Halaas, J. L., Gajiwala, K. S., Maffei, M., Cohen, S. L., Chait, B. T., Rabinowitz, D., Lallone, R. L., Burley, S. K., & Friedman, J. M. (1995) · Science · doi:10.1126/science.7624777 · Cited by 4,451
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Self-citation
The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834
Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,564
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
Neuschwander‐Tetri, B. A., & Caldwell, S. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50193 · Cited by 2,166

Show all 82 references

Research works printed but not linked: 1

Garcia-Ruiz, 1995, Mol. Pharmacol., 48, 825

Sorted by citations

Items 401–500 of 1,005

Premorbid obesity, but not nutrition, prevents critical illness‐induced muscle wasting and weakness
Goossens, C., Marques, M. B., Derde, S., Perre, S. V., Dufour, T., Thiessen, S., Güiza, F., Janssens, T., Hermans, G., Vanhorebeek, I., et al. (2016) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12131 · Cited by 102
ACE Inhibition and AT1 Receptor Blockade Prevent Fatty Liver and Fibrosis in Obese Zucker Rats
Toblli, J. E., Muñoz, M. C., Cao, G., Mella, J. M., Pereyra, L., & Mastaï, R. (2008) · Obesity · doi:10.1038/oby.2007.114 · Cited by 103
PARP1-mediated PPARα poly(ADP-ribosyl)ation suppresses fatty acid oxidation in non-alcoholic fatty liver disease
Huang, K., Du, M., Tan, X., Yang, L., Li, X., Jiang, Y., Wang, C., Zhang, F., Zhu, F., Cheng, M., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.11.020 · Cited by 102
Metformin and metabolic diseases: a focus on hepatic aspects
Zheng, J., Woo, S., Hu, X., Botchlett, R. E., Chen, L., Huo, Y., & Wu, C. (2015) · Frontiers of Medicine · doi:10.1007/s11684-015-0384-0 · Cited by 101
Mitochondrial cholesterol in health and disease.
García‐Ruiz, C., Marí, M., Colell, A., Morales, A., Caballero, F. G., Montero, J., Terrones, O., Basáñez, G., & Fernández-Checa, J. C. (2009) · PubMed · doi:10.14670/hh-24.117 · Cited by 101
The role of bariatric surgery in the management of nonalcoholic fatty liver disease and metabolic syndrome
Aguilar-Olivos, N. E., Almeda-Valdes, P., Aguilar-Salinas, C. A., Uribe, M., & Méndez-Sánchez, N. (2016) · Metabolism · doi:10.1016/j.metabol.2015.09.004 · Cited by 100
1H NMR-based metabolomics approach to evaluate the effect of Xue-Fu-Zhu-Yu decoction on hyperlipidemia rats induced by high-fat diet
Song, X., Wang, J., Wang, P., Tian, N., Yang, M., & Kong, L. (2013) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2013.02.014 · Cited by 100
Lack of Fas antagonism by Met in human fatty liver disease
Zou, C., Ma, J., Wang, X., Guo, L., Zhu, Z., Stoops, J. W., Eaker, A. E., Johnson, C. J., Strom, S. C., Michalopoulos, G. K., et al. (2007) · Nature Medicine · doi:10.1038/nm1625 · Cited by 99
Rosiglitazone Attenuates Age- and Diet-Associated Nonalcoholic Steatohepatitis in Male Low-Density Lipoprotein Receptor Knockout Mice
Gupte, A. A., Liu, J. Z., Ren, Y., Minze, L. J., Wiles, J. R., Collins, A. R., Lyon, C. J., Praticò, D., Finegold, M. J., Wong, S. T. C., et al. (2010) · Hepatology · doi:10.1002/hep.23941 · Cited by 98
TNFα-dependent hepatic steatosis and liver degeneration caused by mutation of zebrafishs-adenosylhomocysteine hydrolase
Matthews, R. P., Lorent, K., Mayoral, R., Huang, Y., Gong, W., Murray, I. V. J., Blair, I. A., & Pack, M. A. (2009) · Development · doi:10.1242/dev.027565 · Cited by 98
Dietary butylated hydroxytoluene improves lipid metabolism, antioxidant and anti-apoptotic response of largemouth bass (Micropterus salmoides)
Liu, Y. X., Yu, H., Liang, X., Li, N. Y., Wang, X., Li, F. H., Wu, X., Zheng, Y., Xue, M., & Liang, X. (2017) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2017.10.054 · Cited by 98
CREBH Regulates Systemic Glucose and Lipid Metabolism
Nakagawa, Y., & Shimano, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051396 · Cited by 98
Intake of trans Fatty Acids Causes Nonalcoholic Steatohepatitis and Reduces Adipose Tissue Fat Content
Machado, R. M., Stefano, J. T., de Oliveira, C. P. M. S., de Mello, E. S., Ferreira, F. D., Nunes, V. S., de Lima, V. M. R., Quintão, E. C. R., Catanozi, S., Nakandakare, E. R., et al. (2010) · Journal of Nutrition · doi:10.3945/jn.109.117937 · Cited by 98
Analysis of the therapeutic functions of novel melanocortin receptor agonists in MC3R- and MC4R-deficient C57BL/6J mice
Kumar, K. G., Sutton, G. M., Dong, J. Z., Roubert, P., Plas, P., Halem, H. A., Culler, M. D., Yang, H., Dixit, V. D., & Butler, A. A. (2009) · Peptides · doi:10.1016/j.peptides.2009.07.012 · Cited by 98
Nonalcoholic fatty liver disease: from pathogenesis to patient care
Perlemuter, G., Bigorgne, A., Cassard, A., & Naveau, S. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0505 · Cited by 98
Genome-Wide mRNA Expression Analysis of Hepatic Adaptation to High-Fat Diets Reveals Switch from an Inflammatory to Steatotic Transcriptional Program
Radonjić, M., de Haan, J. R., van Erk, M. J., van Dijk, K. W., van den Berg, S. A. A., de Groot, P. J., Müller, M. M., & van Ommen, B. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006646 · Cited by 98
Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis
Lee, D. H., Han, D. H., Nam, K. T., Park, J. S., Kim, S. H., Lee, M., Kim, G., Min, B. S., Soo, B., Lee, Y. S., et al. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.09.009 · Cited by 98
HCC Development Is Associated to Peripheral Insulin Resistance in a Mouse Model of NASH
De Minicis, S., Agostinelli, L., Rychlicki, C., Sorice, G. P., Saccomanno, S., Candelaresi, C., Giaccari, A., Trozzi, L., Pierantonelli, I., Mingarelli, E., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097136 · Cited by 97
Effects of flavonoids from Rosa laevigata Michx fruit against high-fat diet-induced non-alcoholic fatty liver disease in rats
Zhang, S., Zheng, L., Dong, D., Xu, L., Yin, L., Qi, Y., Han, X., Lin, Y., Liu, K., & Peng, J. (2013) · Food Chemistry · doi:10.1016/j.foodchem.2013.05.019 · Cited by 97
Nuciferine Prevents Hepatic Steatosis and Injury Induced by a High-Fat Diet in Hamsters
Guo, F., Yang, X., Li, X., Feng, R., Guan, C., Wang, Y., Li, Y., & Sun, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063770 · Cited by 97
Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma
Kanda, T., Goto, T., Hirotsu, Y., Masuzaki, R., Moriyama, M., & Omata, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041525 · Cited by 97
Metabolomics (liver and blood profiling) in a mouse model in response to fasting: A study of hepatic steatosis
Ginneken, V., Verhey, E., Poelmann, R. E., Ramakers, R. E. F. S., van Dijk, K. W., Ham, L., Voshol, P. J., Havekes, L. M., Eck, M. V., & van der Greef, J. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.07.007 · Cited by 97
Does physical inactivity cause nonalcoholic fatty liver disease?
Rector, R. S., & Thyfault, J. P. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00384.2011 · Cited by 97
Oxidative stress inhibits IFN-α-induced antiviral gene expression by blocking the JAK–STAT pathway
Bona, D. D., Cippitelli, M., Fionda, C., Cammà, C., Licata, A., Santoni, A., & Craxı̀, A. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.01.037 · Cited by 96
Carbon monoxide protects against hepatic steatosis in mice by inducing sestrin-2 via the PERK-eIF2α-ATF4 pathway
Kim, H. J., Joe, Y., Kim, S., Park, S., Park, J., Chen, Y., Kim, J., Ryu, J., Cho, G. J., Surh, Y., et al. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.05.026 · Cited by 96
Mangiferin Improves Hepatic Lipid Metabolism Mainly Through Its Metabolite-Norathyriol by Modulating SIRT-1/AMPK/SREBP-1c Signaling
Li, J., Liu, M., Yu, H., Wang, W., Han, L., Chen, Q., Ruan, J., Wen, S., Zhang, Y., & Wang, T. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00201 · Cited by 95
Rho-kinase/AMPK axis regulates hepatic lipogenesis during overnutrition
Hu, H., Lee, S., Sousa‐Lima, I., Kim, S. S., Hwang, W. M., Dagon, Y., Yang, W.-M., Cho, S., Kang, M., Seo, J. A., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci63562 · Cited by 95
Chemerin is highly expressed in hepatocytes and is induced in non-alcoholic steatohepatitis liver
Krautbauer, S., Wanninger, J., Eisinger, K., Hader, Y., Beck, M., Kopp, A., Schmid, A., Weiß, T. S., Dorn, C., & Buechler, C. (2013) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2013.07.009 · Cited by 95
Hepatoprotective effects of aqueous leaf extract and crude isolates of Murraya koenigii against in vitro ethanol-induced hepatotoxicity model
Sathaye, S. S., Bagul, Y. R., Gupta, S., Kaur, H., & Redkar, R. G. (2010) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2010.04.012 · Cited by 95
Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection
Petta, S., Cammà, C., Marco, V. D., Macaluso, F. S., Maida, M. F., Pizzolanti, G., Belmonte, B., Cabibi, D., Stefano, R. D., Ferraro, D., et al. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02453.x · Cited by 94
Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease
Nobili, V., Manco, M., Ciampalini, P., Ciommo, V. M. D., Vito, R. D., Piemonte, F., Comparcola, D., Guidi, R., & Marcellini, M. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02288 · Cited by 94
FTO-dependent function of N6-methyladenosine is involved in the hepatoprotective effects of betaine on adolescent mice
Chen, J., Zhou, X., Wu, W.-C., Wang, X., & Wang, Y. (2015) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-015-0420-1 · Cited by 94
Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
Imajo, K., Yoneda, M., Kessoku, T., Ogawa, Y., Maeda, S., Sumida, Y., Hyogo, H., Eguchi, Y., Wada, K., & Nakajima, A. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141121833 · Cited by 93
Molecular mechanism of alcoholic fatty liver
Rasineni, K., & Casey, C. A. (2012) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.96297 · Cited by 93
Alleviation of hepatic steatosis accompanied by modulation of plasma and liver TNF-α levels by Trigonella foenum graecum (fenugreek) seeds in Zucker obese (fa/fa) rats
Raju, J., & Bird, R. P. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803254 · Cited by 93
Honokiol activates the LKB1–AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes
Seo, M. S., Kim, J. H., Kim, H. J., Chang, K. C., & Park, S. W. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.02.020 · Cited by 93
Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C
García‐Monzón, C., Iacono, O. L., Mayoral, R., González‐Rodríguez, Á., Miquilena-Colina, M. E., Lozano-Rodríguez, T., García-Pozo, L., Vargas‐Castrillón, J., Casado, M., Boscá, L., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.06.021 · Cited by 94
Pre-clinical and clinical investigations of metabolic zonation in liver diseases: The potential of microphysiology systems
Soto–Gutiérrez, A., Gough, A., Vernetti, L. A., Taylor, D. L., & Monga, S. P. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217707731 · Cited by 94
Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
Seghieri, M., Christensen, A. S., Andersen, A., Solini, A., Knop, F. K., & Vilsbøll, T. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00649 · Cited by 92
Lipid-lowering effects of polydatin from Polygonum cuspidatum in hyperlipidemic hamsters
Du, J., Sun, L.-N., Xing, W.-W., Huang, B., Jia, M., Wu, J.-Z., Zhang, H., & Qin, L. (2008) · Phytomedicine · doi:10.1016/j.phymed.2008.10.001 · Cited by 92
Hepatic PPARs: Their Role in Liver Physiology, Fibrosis and Treatment
Zardi, E. M., Navarini, L., Sambataro, G., Piccinni, P., Sambataro, F., Spina, C., & Dobrina, A. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990136 · Cited by 92
Vanillic acid attenuates obesity via activation of the AMPK pathway and thermogenic factors in vivo and in vitro
Jung, Y., Park, J., Kim, H., Sim, J., Youn, D., Kang, J., Lim, S., Jeong, M., Yang, W. M., Lee, S., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201700231rr · Cited by 91
Free radicals, antioxidants, nuclear factor‐E2‐related factor‐2 and liver damage
Ramos‐Tovar, E., & Muriel, P. (2019) · Journal of Applied Toxicology · doi:10.1002/jat.3880 · Cited by 91
Emerging Role of Hepatic Ketogenesis in Fatty Liver Disease
Mooli, R. G. R., & Ramakrishnan, S. K. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.946474 · Cited by 92
Adipose Overexpression of Phosphoenolpyruvate Carboxykinase Leads to High Susceptibility to Diet-Induced Insulin Resistance and Obesity
Franckhauser, S., MUÑOZ, S. A., Elias, I., Ferré, T., & Bosch, F. (2006) · Diabetes · doi:10.2337/diabetes.55.02.06.db05-0482 · Cited by 91
Lipotoxicity and steatohepatitis in an overfed mouse model for non-alcoholic fatty liver disease
Gaemers, I. C., Stallen, J., Kunne, C., Wallner, C., van Werven, J. R., Nederveen, A. J., & Lamers, W. H. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.01.003 · Cited by 90
Baicalin inhibits autophagy induced by influenza A virus H3N2
Zhu, H., Han, L., Shi, X., Wang, B., Huang, H. Y., Wang, X., Chen, D., Ju, D., & Feng, M. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.11.003 · Cited by 90
Camel milk ameliorates steatohepatitis, insulin resistance and lipid peroxidation in experimental non-alcoholic fatty liver disease
Korish, A. A., & Arafah, M. (2013) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-13-264 · Cited by 90
Lipoprotein subclass metabolism in nonalcoholic steatohepatitis
Männistö, V., Simonen, M., Soininen, P., Tiainen, M., Kangas, A. J., Kamińska, D., Venesmaa, S., Käkelä, P., Kärjä, V. J., Gylling, H., et al. (2014) · Journal of Lipid Research · doi:10.1194/jlr.p054387 · Cited by 90
Peroxisome proliferator‐activated receptor‐α agonist, Wy 14 643, improves metabolic indices, steatosis and ballooning in diabetic mice with non‐alcoholic steatohepatitis
Larter, C. Z., Yeh, M. M., Van Rooyen, D. M., Brooling, J., Ghatora, K., & Farrell, G. C. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06939.x · Cited by 89
Mammalian phospholipase D: Function, and therapeutics
McDermott, M. I., Wang, Y., Wakelam, M. J. O., & Bankaitis, V. A. (2019) · Progress in Lipid Research · doi:10.1016/j.plipres.2019.101018 · Cited by 89
Deletion of Nrf2 leads to rapid progression of steatohepatitis in mice fed atherogenic plus high-fat diet
Okada, K., Warabi, E., Sugimoto, H., Horie, M., Gotoh, N., Tokushige, K., Hashimoto, E., Utsunomiya, H., Takahashi, H., Ishii, T., et al. (2012) · Journal of Gastroenterology · doi:10.1007/s00535-012-0659-z · Cited by 89
Medium‐chain fatty acids ameliorate insulin resistance caused by high‐fat diets in rats
Wein, S., Wolffram, S., Schrezenmeir, J., Gašperíková, D., Klimeś, I., & ŠEBÖKOVÁ, E. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.925 · Cited by 89
Inhibiting glycosphingolipid synthesis ameliorates hepatic steatosis in obese mice #
Zhao, H., Przybylska, M., Wu, I., Zhang, J., Maniatis, P., Pacheco, J., Piepenhagen, P. A., Copeland, D., ARBEENY, C. M., Shayman, J. A., et al. (2009) · Hepatology · doi:10.1002/hep.22970 · Cited by 89
Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver
Lopetuso, L. R., Mocci, G., Marzo, M., D’Aversa, F., Rapaccini, G. L., Guidi, L., Armuzzi, A., Gasbarrini, A., & Papa, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082199 · Cited by 89
The effects of quercetin supplementation on lipid profiles and inflammatory markers among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials
Tabrizi, R., Tamtaji, O. R., Mirhosseini, N., Lankarani, K. B., Akbari, M., Heydari, S. T., Dadgostar, E., & Asemi, Z. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2019.1604491 · Cited by 88
In situ visualization of peroxisomal viscosity in the liver of mice with non-alcoholic fatty liver disease by near-infrared fluorescence and photoacoustic imaging
Zhou, Y., Li, P., Wang, X., Wu, C., Fan, N., Liu, X., Wu, L., Zhang, W., Zhang, W., Liu, Z., et al. (2020) · Chemical Science · doi:10.1039/d0sc02922j · Cited by 88
Hepatic Lipid Metabolism Disorder and Atherosclerosis
Zhang, S., Hong, F., Ma, C., & Yang, S. (2021) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530322666211220110810 · Cited by 88
Berberine-loaded solid lipid nanoparticles are concentrated in the liver and ameliorate hepatosteatosis in db/db mice
Xue, M., Zhang, L., Yang, M., Zhang, W., Li, X.-M., Ou, Z., Li, Z., Liu, S.-H., Li, X., & Yang, S. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s84565 · Cited by 89
Monocyte chemoattractant protein-1 secreted by adipose tissue induces direct lipid accumulation in hepatocytes
Clément, S., Juge-Aubry, C. E., Sgroi, A., Conzelmann, S., Pazienza, V., Pittet-Cuenod, B. M., Meier, C. A., & Negro, F. (2008) · Hepatology · doi:10.1002/hep.22404 · Cited by 88
Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis
Beraza, N., Malato, Y., Borght, S. V., Liedtke, C., Wasmuth, H. E., Dréano, M., Vos, R. D., Roskams, T., & Trautwein, C. (2008) · Gut · doi:10.1136/gut.2007.134288 · Cited by 88
Gastrointestinal Complications of Diabetes
Boland, B. S., Edelman, S. V., & Wolosin, J. D. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.07.006 · Cited by 88
Hepatic growth hormone and glucocorticoid receptor signaling in body growth, steatosis and metabolic liver cancer development
Mueller, K. M., Themanns, M., Friedbichler, K., Kornfeld, J., Esterbauer, H., Tuckermann, J. P., & Moriggl, R. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.03.026 · Cited by 88
The protective role of amla (Emblica officinalisGaertn.) against fructose-induced metabolic syndrome in a rat model
Kim, H. Y., Okubo, T., Juneja, L. R., & Yokozawa, T. (2009) · British Journal Of Nutrition · doi:10.1017/s0007114509991978 · Cited by 88
Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue
Kudo, H., Yata, Y., Takahara, T., Kawai, K., Nakayama, Y., Kanayama, M., Oya, T., Morita, S., Sasahara, M., Mann, D. A., et al. (2009) · Liver International · doi:10.1111/j.1478-3231.2009.02006.x · Cited by 88
Inhibition of Arachidonic Acid and Iron-Induced Mitochondrial Dysfunction and Apoptosis by Oltipraz and Novel 1,2-Dithiole-3-thione Congeners
Shin, S. M., & Kim, S. G. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.051128 · Cited by 88
Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice
Larter, C. Z., Yeh, M. M., Rooyen, D. M. V., Teoh, N., Brooling, J. T., Hou, J. Y., Williams, J., Clyne, M., Nolan, C. J., & Farrell, G. C. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05996.x · Cited by 87
In Vivo Hyperpolarized Carbon-13 Magnetic Resonance Spectroscopy Reveals Increased Pyruvate Carboxylase Flux in an Insulin-Resistant Mouse Model
Lee, P., Leong, W., Tan, T., Lim, M., Han, W., & Radda, G. K. (2012) · Hepatology · doi:10.1002/hep.26028 · Cited by 87
Roles of Acyl-CoA:Diacylglycerol Acyltransferases 1 and 2 in Triacylglycerol Synthesis and Secretion in Primary Hepatocytes
Li, C., Li, L., Lian, J., Watts, R., Nelson, R., Goodwin, B. J., & Lehner, R. S. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304584 · Cited by 87
Multiparametric MRI in Patients With Nonalcoholic Fatty Liver Disease
Schaapman, J. J., Tushuizen, M. E., Coenraad, M. J., & Lamb, H. J. (2020) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.27292 · Cited by 86
Mitochondrial dysfunction contributes to the increased vulnerabilities of adiponectin knockout mice to liver injury†
Zhou, M., Xu, A., Tam, P. K. H., Lam, K. S. L., Chan, L., Hoo, R. L. C., Liu, J., Chow, H., & Wang, Y. (2008) · Hepatology · doi:10.1002/hep.22444 · Cited by 86
Central Nervous System Agents for Ischemic Stroke: Neuroprotection Mechanisms
Pandya, R. S., Mao, L., Zhou, H., Zhou, S., Zeng, J., Popp, A., & Wang, X. (2011) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/187152411796011321 · Cited by 86
Overexpression of c-myc in hepatocytes promotes activation of hepatic stellate cells and facilitates the onset of liver fibrosis
Nevzorova, Y. A., Hu, W., Cubero, F. J., Haas, U., Freimuth, J., Tacke, F., Trautwein, C., & Liedtke, C. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.06.001 · Cited by 86
The Non-coding RNA gadd7 Is a Regulator of Lipid-induced Oxidative and Endoplasmic Reticulum Stress
Brookheart, R. T., Michel, C. I., Listenberger, L. L., Ory, D. S., & Schaffer, J. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806209200 · Cited by 86
Acetyl-CoA Carboxylase 2−/− Mutant Mice are Protected against Fatty Liver under High-fat, High-carbohydrate Dietary and de Novo Lipogenic Conditions
Abu-Elheiga, L. A., Wu, H., Gu, Z., BRESSLER, R. C., & Wakil, S. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.309559 · Cited by 85
The transcription factor carbohydrate-response element-binding protein (ChREBP): A possible link between metabolic disease and cancer
Iizuka, K. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.11.029 · Cited by 85
Non-alcoholic Fatty Liver Disease in Children
Manco, M., Bottazzo, G. F., Vito, R. D., Marcellini, M., Mingrone, G., & Nobili, V. (2008) · touchREVIEWS in Endocrinology · doi:10.1080/07315724.2008.10719744 · Cited by 85
Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: Risk and prognosis prediction
Hassan, M. M., Kaseb, A. O., Etzel, C. J., El‐Serag, H. B., Spitz, M. R., Chang, P., Stemke‐Hale, K., Liu, M., Rashid, A., Shama, M., et al. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.22057 · Cited by 85
Relation of Uric Acid to Serum Levels of High-Sensitivity C-Reactive Protein, Triglycerides, and High-Density Lipoprotein Cholesterol and to Hepatic Steatosis
Keenan, T. E., Blaha, M. J., Nasir, K., Silverman, M. G., Tota-Maharaj, R., Carvalho, J. A. M., Conceição, R., Blumenthal, R. S., & Santos, R. D. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.08.012 · Cited by 85
Role of metabolic lipases and lipolytic metabolites in the pathogenesis of NAFLD
Fuchs, C. D., Claudel, T., & Trauner, M. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.08.001 · Cited by 85
Nutrition and Nonalcoholic Fatty Liver Disease: The Significance of Cholesterol
Enjoji, M., Yasutake, K., Kohjima, M., & Nakamuta, M. (2012) · International Journal of Hepatology · doi:10.1155/2012/925807 · Cited by 85
Hepatic steatosis: A benign disease or a silent killer
El‐Zayadi, A. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.4120 · Cited by 85
c-MYC—Making Liver Sick: Role of c-MYC in Hepatic Cell Function, Homeostasis and Disease
Zheng, K., Cubero, F., & Nevzorova, Y. (2017) · Genes · doi:10.3390/genes8040123 · Cited by 84
Metabolic insights from zebrafish genetics, physiology, and chemical biology
Schlegel, A., & Gut, P. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1816-8 · Cited by 84
Dihydromyricetin ameliorates oleic acid-induced lipid accumulation in L02 and HepG2 cells by inhibiting lipogenesis and oxidative stress
Xie, C., Chen, Z., Zhang, C., Xu, X. Y., Jin, J., Zhan, W., Han, T., & Wang, J. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.06.001 · Cited by 84
A metabolomics cell-based approach for anticipating and investigating drug-induced liver injury
García‐Cañaveras, J. C., Castell, J. V., Donato, M. T., & Lahoz, A. (2016) · Scientific Reports · doi:10.1038/srep27239 · Cited by 84
Resveratrol inhibits LXRα-dependent hepatic lipogenesis through novel antioxidant Sestrin2 gene induction
Jin, S. H., Yang, J. H., Shin, B. Y., Seo, K., Shin, S. M., Cho, I. J., & Ki, S. H. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.04.023 · Cited by 83
Microarray analyses and molecular profiling of steatosis induction in immortalized human hepatocytes
Gottardi, A. D., Vinciguerra, M., Sgroi, A., Moukil, M. A., Ravier, F., Pazienza, V., Pugnale, P., Foti, M., & Hadengue, A. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700590 · Cited by 83
Diet high in fructose promotes liver steatosis and hepatocyte apoptosis in C57BL/6J female mice: Role of disturbed lipid homeostasis and increased oxidative stress
Choi, Y., Abdelmegeed, M. A., & Song, B. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.02.039 · Cited by 83
Circadian- and UPR-dependent control of CPEB4 mediates a translational response to counteract hepatic steatosis under ER stress
Maillo, C., Martín, J., Sebastián, D., Hernández-Alvarez, M., García-Rocha, M., Reina, O., Zorzano, A., Fernandez, M., & Méndez, R. (2017) · Nature Cell Biology · doi:10.1038/ncb3461 · Cited by 82
Bile acid receptors and nonalcoholic fatty liver disease
Yuan, L. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i28.2811 · Cited by 82
Beneficial effect of a weight-stable, low-fat/low-saturated fat/low-glycaemic index diet to reduce liver fat in older subjects
Utzschneider, K. M., Bayer-Carter, J. L., Arbuckle, M. D., Tidwell, J. M., Richards, T. L., & Craft, S. (2013) · British Journal of Nutrition · doi:10.1017/s0007114512002966 · Cited by 81
Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coin
Acierno, C., Caturano, A., Pafundi, P. C., Nevola, R., Adinolfi, L. E., & Sasso, F. C. (2020) · Exploration of Medicine · doi:10.37349/emed.2020.00019 · Cited by 81
Serum Fragmented Cytokeratin 18 Levels Reflect the Histologic Activity Score of Nonalcoholic Fatty Liver Disease More Accurately Than Serum Alanine Aminotransferase Levels
Tsutsui, M., Tanaka, N., Kawakubo, M., Sheena, Y., Horiuchi, A., Komatsu, M., Nagaya, T., Joshita, S., Umemura, T., Ichijo, T., et al. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181bdefe2 · Cited by 81
Lipotoxicity in renal proximal tubular cells: Relationship between endoplasmic reticulum stress and oxidative stress pathways
Katsoulieris, E. N., Mabley, J. G., Samai, M. H., Sharpe, M. A., Green, I. C., & Chatterjee, P. K. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.03.021 · Cited by 81
Activation of aryl hydrocarbon receptor dissociates fatty liver from insulin resistance by inducing fibroblast growth factor 21
Lu, P., Yan, J., Liu, K., Garbacz, W. G., Wang, P., Xu, M., Ma, X., & Xie, W. (2015) · Hepatology · doi:10.1002/hep.27719 · Cited by 80
Down-regulation of transcription factor peroxisome proliferator-activated receptor in programmed hepatic lipid dysregulation and inflammation in intrauterine growth–restricted offspring
Magee, T. R., Han, G., Cherian, B., Khorram, O., Ross, M. G., & Desai, M. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.05.022 · Cited by 80
Wogonin induces apoptosis by activating the AMPK and p53 signaling pathways in human glioblastoma cells
Lee, D., Lee, T. H., Jung, C. H., & Kim, Y.-H. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.07.019 · Cited by 80
Ketone body production is differentially altered in steatosis and non‐alcoholic steatohepatitis in obese humans
Männistö, V., Simonen, M., Hyysalo, J., Soininen, P., Kangas, A. J., Kamińska, D., Matte, A. K., Venesmaa, S., Käkelä, P., Kärjä, V. J., et al. (2014) · Liver International · doi:10.1111/liv.12769 · Cited by 80
Obesity and inflammation in children
Schwarzenberg, S. J., & Sinaiko, A. R. (2006) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2006.08.002 · Cited by 80

Authors: Browning, J. D., & Horton, J. D.
Affiliations: The University of Texas Southwestern Medical Center (US)
Corresponding author: Horton, Jay D.
ORCID: Horton, Jay D.
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 2004-07-15
Volume: 114
Issue: 2
Pages: 147-152
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci200422422
PMC: PMC449757
OpenAlex: W4230280576
Cited by: 1,772
References: 82
Citations by year: 2026: 18 · 2025: 32 · 2024: 45 · 2023: 50 · 2022: 73 · 2021: 72 · 2020: 75 · 2019: 100 · 2018: 104 · 2017: 89 · 2016: 102 · 2015: 109 · 2014: 90 · 2013: 104 · 2012: 103
FWCI: 48.64
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed Central (publishedVersion)
Funders: American Liver Foundation
National Institutes of Health (HL20948)
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords: hepatic steatosis, liver injury, non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, molecular mediators, lipid metabolism, reactive oxygen species, oxidative stress, mitochondrial dysfunction, lipid peroxidation, acetyl-CoA carboxylase, AMPK, ChREBP, stearoyl-CoA desaturase, polyunsaturated fatty acids, malondialdehyde

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Molecular mediators of hepatic steatosis and liver injury

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks